Award will support the advancement of underrepresented minority participation in COVID-19 clinical trials and contribute to the continued evaluation of FDA-approved products
Date: May 31, 2022
Media Contacts:
Shelby Purdy
361-221-0606
shelbypurdy@tamu.edu
Maureen Thielemans
703-408-6140
mthielemans@aacp.org
KINGSVILLE (May 31, 2022) -- Researchers from the Texas A&M University Irma Lerma Rangel College of Pharmacy and the American Association of Colleges of Pharmacy (AACP) have been awarded $1 million from the United States Food and Drug Administration (FDA) Office of Minority Health and Health Equity (OMHHE) Innovation award: Covid-19 and Health Equity. Through this collaboration with FDA OMHHE, Texas A&M and AACP aim to advance enrollment of underrepresented minorities (URM) in clinical trials, highlighting the unique role community pharmacies and pharmacists have as clinical researchers in recruiting URM populations as clinical trial participants.
The project “Pharmacy Advances Clinical Trials (PACT) Network to Achieve Diversity in COVID Clinical Trials: A Strategic Framework”, will work to achieve two main aims. The first aim, led by Texas A&M, will be to leverage artificial intelligence (AI) and machine learning to enable environmental scans in communities to optimize URM participation in COVID-19 clinical trials. The second aim, led by the AACP, will be to create and train a network of community-based investigators, pharmacists, and other partners to directly increase clinical trials participation among URM populations. The PACT Network will be able to utilize the results of these innovative AI and machine learning tools to help identify and recruit clinical trial participants.
The Texas A & M College of Pharmacy efforts are being led by principal investigator George Udeani, PharmD, DSc, FCP, FCCP, clinical professor and head of the Department of Pharmacy Practice. Udeani has been passionate about this scope of work since pursuing a six-year postdoctoral training in drug development with the National Cancer Institute-National Institutes of Health, where one of his goals was to gain the trust of URMs, improve their access to care, and increase participation in the drug development process. He feels participation in clinical trials will decrease URM morbidity and mortality and offer improved quality of life. He has spent three decades of his career in education, patient care and research at URM communities, working to achieve these objectives. Udeani also has first-hand experience in COVID-19 clinical trials. “What we’ve seen is a lack of trust. There is a hesitancy, and we want to change the narrative,” Udeani said. This collaborative effort will also include investigators from Texas A&M University Health Science Center (Texas A&M Health), School of Public Health and the Coastal Bend Health Education Center. AACP will work on bringing a culture of PACT awareness to pharmacy schools, survey schools for clinical trial research, and design and develop training materials. They will involve accredited colleges and schools of pharmacy, and the Community Pharmacy Enhanced Services Network (CPESN), to identify community pharmacies to engage in the PACT network. AACP also will enroll, train and educate PACT investigators and community pharmacists. AACP and its members have a rich history of developing networks to improve public health, including a partnership with APhA’s Vaccine Confidence Campaign to increase vaccination confidence and combat vaccine misinformation, as well as with the CDC to educate the public on smoking cessation.
“AACP is so pleased to collaborate with our Texas A&M colleagues to expand the capacity to engage with URM candidates for clinical trials”, said Lucinda L. Maine, R.Ph., Ph.D., AACP Executive Vice President and CEO. We know that many of our members have experience in the conduct of such research and the PACT network offers a unique opportunity to coalesce the insights from across the country in a manner that creates a collective force for good.”
“The College of Pharmacy’s commitment of transforming lives through reimagining pharmacy resonates well with AACP’s vision of a world of healthy people through the transformation of health professions education. Both organizations are passionate about advancing pharmacy education and improving health for all. This, first of its kind, model of institutional member-AACP partnership is not only a worthy endeavor but also can model the way for many such impactful partnerships in the future,” Indra Reddy, PhD, professor and dean of the College of Pharmacy said.
“OMHHE strives to eliminate health disparities through strategic communication, community outreach, and innovative collaborative research. OMHHE knows we cannot achieve our mission alone. Through partnerships, collaborations, multi-stakeholder engagement, and fostering a collaborative learning environment we aim to achieve sustainable health equity and generate impact across diverse communities. Today and every day, we pledge to continue this important work in support of diverse communities across the country, with the goal of achieving health equity for all,” said RADM Richardae Araojo PharmD, MS, FDA Associate Commissioner of Minority Health and Director of Minority Health.
The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.
###